Hympavzi 150 mg, Injektionslösung im Fertigpen
7680695560015
CH-69556
Injektionslösung im Fertigpen
Associated product:
HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Stück
- Galenic form
- Injektionslösung im Fertigpen
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
marstacimabum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.0062 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 6884.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69556
- Drug name
- Hympavzi, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- B02BX11
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 23/12/2024
- Authorization expiration date
- 22/12/2029
- IT Number
- 06.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
- Description (DE)
- HYMPAVZI Inj Lös 150 mg/ml Fertpen 1 ml
- Market launch
- 23/12/2024
- Narcotic (BTM)
- No